Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue
Sustained complement activation is an underlying pathologic driver in many inflammatory and autoimmune diseases. Currently approved anti-complement therapies are directed at the systemic blockade of complement. Consequently, these therapies provide widespread inhibition of complement pathway activit...
Main Authors: | Kelly C. Fahnoe, Fei Liu, Jennifer G. Morgan, Sarah T. Ryan, Michael Storek, Ellen Garber Stark, Fred R. Taylor, V. Michael Holers, Joshua M. Thurman, Stefan Wawersik, Susan L. Kalled, Shelia M. Violette |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.869725/full |
Similar Items
-
The effect of splenectomy on complement regulatory proteins in erythrocytes in β-thalassemia major
by: Ayşegül Uğur Kurtoğllu, et al.
Published: (2018-12-01) -
Complement Evasion: An Effective Strategy That Parasites Utilize to Survive in the Host
by: Shuai Shao, et al.
Published: (2019-03-01) -
Effect of Heme Oxygenase-1 Depletion on Complement Regulatory Proteins Expression in the Rat
by: Maria G. Detsika, et al.
Published: (2022-12-01) -
The Defensive Interactions of Prominent Infectious Protozoan Parasites: The Host’s Complement System
by: Sajad Rashidi, et al.
Published: (2022-10-01) -
Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection
by: Damian A. Oyong, et al.
Published: (2019-09-01)